| PERIOD ENDING | 30-Jan-10 | 31-Oct-09 | 1-Aug-09 | 2-May-09 | | Total Revenue | 898,217 | 884,768 | 853,491 | 889,538 | | Cost of Revenue | 731,611 | 720,167 | 691,415 | 720,787 | | | Gross Profit | 166,606 | 164,601 | 162,076 | 168,751 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 139,002 | 137,409 | 133,478 | 138,327 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,604 | 27,192 | 28,598 | 30,424 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 | 77 | 125 | (146) | | Earnings Before Interest And Taxes | 27,656 | 27,269 | 28,723 | 30,278 | | Interest Expense | 1,557 | 1,381 | 1,581 | 1,722 | | Income Before Tax | 26,099 | 25,888 | 27,142 | 28,556 | | Income Tax Expense | 10,440 | 10,355 | 11,605 | 11,777 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,659 | 15,533 | 15,537 | 16,779 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,659 | 15,533 | 15,537 | 16,779 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,659 | $15,533 | $15,537 | $16,779 |
|
0.35% Nasdaq 
0.36 (1.27%) 
Income Statement
